Found: 1
Select item for more details and to access through your institution.
A Pilot Study of Omalizumab to Treat Oxaliplatin-Induced Hypersensitivity Reaction.
- Published in:
- Oncology (08909091), 2022, v. 36, n. 7, p. 414
- By:
- Publication type:
- Article